New Products: PacBio's SMRT Analysis 2.2

Apr 01, 2014

Premium

Pacific Biosciences has released SMRT Analysis 2.2, a software upgrade that will support the Iso-Seq application for full-length transcript sequencing, as well as HLA allele phasing. The SMRT Analysis software upgrade is available for download from PacBio's DevNet website.

Filed under

Clinical Sequencing

Sequencing

Next-Generation Sequencing

Pacific Biosciences

New Products: PacBio's SMRT Analysis 2.2

Filed under

10x Genomics' Share Price Tumbles as Preliminary Q3 Revenues Show 1 Percent Drop

Clock.bio Raises $5.3M in Seed Funding to Support Human Longevity Research

Dementia Contributors Uncovered Using Neuropathy Endophenotype-Focused Strategies

Protein Computation Pioneers Share 2024 Nobel Prize in Chemistry

Delve Bio, Broad Clinical Labs Partner for Metagenomic Infectious Disease Sequencing

Illumina Launches Push-Button Sequencing With New Low-Throughput MiSeq i100 Line
Premium

Clock.bio Raises $5.3M in Seed Funding to Support Human Longevity Research

LGC Clinical Diagnostics, AccuGenomics Partner to Develop NGS Quality Control Materials

Delve Bio, Broad Clinical Labs Partner for Metagenomic Infectious Disease Sequencing

High PRS Equivalent to Rare Monogenic Risk Variants in Certain Cases in UK Biobank Population
Premium

New Products: PacBio's SMRT Analysis 2.2

Filed under

Illumina Launches Push-Button Sequencing With New Low-Throughput MiSeq i100 Line Premium

High PRS Equivalent to Rare Monogenic Risk Variants in Certain Cases in UK Biobank Population Premium

Illumina Launches Push-Button Sequencing With New Low-Throughput MiSeq i100 Line
Premium

High PRS Equivalent to Rare Monogenic Risk Variants in Certain Cases in UK Biobank Population
Premium